| Literature DB >> 35559348 |
Novia Niannian Long1, Michele Petrova Xin Ling Lau1, Ainsley Ryan Yan Bin Lee1, Natalie Elizabeth Yam1, Nicholas Ye Kai Koh1, Cyrus Su Hui Ho2.
Abstract
Introduction: Colorectal cancer screening when done early can significantly reduce mortality. However, screening compliance is still lower than expected even in countries with established screening programs. Motivational interviewing is an approach that has been explored to promote behavioral change including screening compliance. This review synthesizes the efficacy of motivational interviewing in promoting uptake of colorectal screening modalities and is the only review so far that examines motivational interviewing for colorectal cancer screening alone.Entities:
Keywords: behavioral science; cancer screening; colorectal cancer; motivational interviewing; preventative medicine; psychology; systematic review
Year: 2022 PMID: 35559348 PMCID: PMC9090440 DOI: 10.3389/fmed.2022.889124
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
FIGURE 1PRISMA flowchart of study selection.
Summary of study characteristics and findings.
| Study | Study design | Participants | MI-containing intervention | Comparator group(s) | Outcome(s) of interest | Main findings |
| Adegboyega et al. ( | RCT | 50 and above, rural Appalachian resident with no history of CRC and no completion of CRC tests | Completion rate of CRC screening at either 3 or 6 months | No difference in the rate of CRC screening by study group (χ2=0.13, | ||
| Arnold et al. ( | RCT | Patients aged 50–75, without previous history of cancer, not up to date with CRC screening, does not have a first-degree relative with history of CRC | FIT return rate within 12 months | No difference was found in the effectiveness of PC over AC. | ||
| Broc et al. ( | RCT | 50–74-year-old men and women with an average risk of CRC | FOBT performed within 90 days | PP analysis: a 9.2% screening participation rate for controls (1,781/19,400), 18.8 and 19.9% for those that received some degrees of MI and IC, respectively ( | ||
| Costanza et al. ( | RCT | Patients between 50 and 75 years old with no colonoscopy in the last 10 years | Completion rate of any CRC screening test | No difference in screening rates between intervention and control arms. | ||
| Denis et al. ( | RCT | Residents aged 50–74 who had not complied after two mailed invitations to visit their GP for CRC screening | gFOBT screening 1 year after intervention | ITT analysis: no difference was found in screening rates between intervention groups taken together (13.9%, 95% CI 13.5–14.4) and the control group (13.9%, 95% CI 13.4–14.4) at 1 year. | ||
| Fortuna et al. ( | RCT | Patients aged 50–74 overdue for CRC screening | CRC screening (FOBT, FIT, colonoscopy, flexible sigmoidoscopy, double contrast barium enema reports) 3 months after intervention | Letter + Personal Call group has a higher screening rate compared to letter alone for CRC (21.5% vs. 12.2%; AOR 2.0, 95% CI 1.1–3.9) | ||
| Kinney et al. ( | Cluster RCT | 30–74-year old first degree relatives of CRC patients due for a colonoscopy | Medically verified colonoscopy at 9 months | PP: 35.4% ( | ||
| Lowery et al. ( | RCT | Aged 21 and above first degree relatives of patients with CRC diagnosed under 60 years old due for a screening during the 2-year study period | Colonoscopy screening reported in at least one of the follow-up mailed surveys at 6, 12 and 24 months with medically verified endoscopy reports | PP analysis: The prevalence of adherence for tailored and mailed intervention were 43.2 and 52.1% at baseline and were 54.0 and 49.8% at 24 months ( | ||
| Manne et al. ( | RCT | Siblings of patients diagnosed with CRC less than 61 years old | Colonoscopy or FS and FOBT 6–8 months after baseline | No significant increase in screening rate in TP+TC group compared to TP group | ||
| Menon et al. ( | RCT | Participants 50 years or older; having no personal or family history of CRC, non-adherent to screening | Completion of any screening test (stool blood test, sigmoidoscopy, or colonoscopy) within 12 months of the intervention | Interventions not significantly associated with greater probability of screening compared with usual care while tailored counseling was significantly more effective than control ( | ||
| Salimzadeh et al. ( | RCT | First-degree relatives (FDRs) of patients diagnosed with CRC under the age of 60, due for a colonoscopy | Completion of colonoscopy within 6 months | 83.5% screening attendance in the intervention vs. 48.2% in the control group (COR = 5.4; 95% CI 2.9–10.0) | ||
| Vernon et al. ( | Stepped randomized trial | Vietnam-era U.S. military Veterans 50 years old and above overdue for CRC screening | Self-reported completion of screening 9 months after each step and 18 months after both steps | No difference between Step 1 intervention groups and control. | ||
| Turner et al. ( | RCT | Patients who missed more than 75% of their primary care appointments, with a colonoscopy scheduled at designated endoscopy suites, not ready to attend the appointment | Rate of colonoscopy appointment attendance within 2 weeks | Peer coach intervention group had over two-fold greater adjusted odds ratios (2.14, 95% CI 0.99–4.63, | ||
| Lasser et al. ( | RCT | Patients aged 52–74 years old not up-to-date with CRC screening | Completion of any CRC screening tests within 1 year based on medical records | 33.6% of the intervention group vs. 20.0% of the control group underwent screening by 1 year ( |
CRC, colorectal cancer; MI, motivational interviewing; RCT, randomized controlled trial; FDR, first-degree relative; PC, personal call; AC, automated call; IC, individualized counseling; CATI, computer-assisted telephone interview; TP, tailored print; TC, telephone counseling; FIT, fecal immunochemical test; (g)FOBT, (guaiac) fecal occult blood test; PP, per-protocol; ITT, intention-to-treat; (A/C)OR, (adjusted/crude) odds ratio; CI, confidence interval; HR, hazard ratio; GP, general practitioner; US, United States. *Comparator group used in the meta-analysis for studies with more than one comparator group.
FIGURE 2Risk of bias assessment.
FIGURE 3Intention-to-treat analysis forest plot.
FIGURE 4Per-protocol analysis forest plot.
Subgroup differences in screening rates stratified by outcome measure time frame.
| Screening rate measured | Studies | Subgroup total ( | Risk (95% CI) | Test for subgroup effect ( | |
|
| |||||
| ≤3 months | Fortuna et al. ( | 3 | 1.1737 (0.9835, 1.4008) | 45.1 | 0.3022 |
| 3 < | Kinney et al. ( | 3 | 1.5979 (1.1266, 2.2662) | 69.5 | 0.3022 |
| ≥12 months | Denis et al. ( | 3 | 1.2268 (0.8855, 1.6997) | 81.8 | 0.3022 |
|
| |||||
| ≤3 months | Broc et al. ( | 2 | 2.0470 (0.8318, 5.0374) | 97.8 | 0.8390 |
| 3 < | Kinney et al. ( | 3 | 1.6851 (1.2511, 2.2696) | 61.7 | 0.8390 |
| ≥12 months | Menon et al. ( | 3 | 1.9331 (1.6988, 1.9781) | 0.0 | 0.8390 |
CI = confidence interval.
Subgroup differences in screening rates stratified by CRC screening modalities.
| CRC screening modality | Studies | Subgroup total ( | Risk (95% CI) | Test for subgroup effect ( | |
|
| |||||
| Colonoscopy | Kinney et al. ( | 4 | 1.4736 (1.0985, 1.9769) | 72.9 | 0.0044 |
| FIT/FOBT only | Broc et al. ( | 2 | 1.0439 (0.9576, 1.1380) | 82.0 | 0.0044 |
| Mixed | Fortuna et al. ( | 3 | 1.4914 (1.1612, 1.9156) | 24.1 | 0.0044 |
|
| |||||
| Colonoscopy | Kinney et al. ( | 4 | 1.5608 (1.2161, 2.0033) | 65.3 | 0.3421 |
| FIT FOBT only | Broc et al. ( | 2 | 2.4253 (1.3963, 4.2124) | 98.9 | 0.3421 |
| Mixed | Costanza et al. ( | 3 | 1.5863 (1.2291, 2.0474) | 50.8 | 0.3421 |
CRC, colorectal cancer; CI, confidence interval; FIT, fecal immunochemical test; FOBT, fecal occult blood test.